Dieter Muri

Title: Dieter Muri: Innovator in Radiolabeled Compounds

Introduction

Dieter Muri is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of radiolabeled compounds. With a total of 9 patents to his name, Muri's work has advanced the understanding and application of imaging tools in pharmaceuticals.

Latest Patents

Among his latest patents, Muri has developed a radiolabeled cannabinoid receptor 2 ligand. This invention relates to a compound of formula (I), wherein R, R, and R are defined as in the description and claims. The compound can be utilized as a radiolabeled ligand, showcasing its potential in medical imaging. Another notable patent involves 2-hetaryl imidazol[1,2-a]pyridine derivatives. This invention focuses on small molecule imaging tools, specifically compounds of formula II and their pharmaceutically acceptable acid addition salts, with R-R having values defined in the specification.

Career Highlights

Dieter Muri has worked with notable companies such as Hoffmann-La Roche Inc. and ETH Zurich. His experience in these esteemed organizations has allowed him to refine his expertise in the field of medicinal chemistry and contribute to groundbreaking research.

Collaborations

Muri has collaborated with several professionals in his field, including Luca Claudio Gobbi and Matthias Koerner. These collaborations have further enriched his research and innovation efforts.

Conclusion

Dieter Muri's contributions to the field of radiolabeled compounds and imaging tools have made a significant impact on medicinal chemistry. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and technology.